Why the study?
Does a long-PCR-based method accurately detect Familial Hyperaldosteronism Type I across all age groups?
Population
Individuals of all ages, from neonates to the elderly, from families with known or suspected Familial…
Design
Case_series
Authors
Loading...
Long-PCR may aid FH-I family screening; leaves open prospective validation before changing practice.
Does a long-PCR-based method accurately detect Familial Hyperaldosteronism Type I across all age groups?
Long-PCR is a reliable and rapid method for screening individuals of all ages for Familial Hyperaldosteronism Type I, enabling early detection and targeted treatment to prevent severe complications like stroke.
Stowasser et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: